Post-approval studies (Phase 4)Study completedNCT01259531
What this trial is testing
Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)
Who this might be right for
Benign Prostatic Hyperplasia
JW Pharmaceutical 100